Related Experiment Video

Updated: Aug 6, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Pharmacokinetics: selectivity of action related to physicochemical properties and kinetic patterns of anticancer

C A Nichol

    Cancer
    |July 1, 1977
    PubMed

    Insights

    Optimizing cancer drug delivery requires precise dosing and scheduling. Advances in pharmacokinetics and compartmental modeling enable targeted cancer chemotherapy for improved efficacy and reduced toxicity.

    Area of Science:

    • Pharmacology
    • Oncology
    • Pharmacokinetics

    Background:

    • Cancer drug therapy is limited by a narrow therapeutic index, necessitating precise drug delivery to maximize efficacy and minimize toxicity.
    • Optimal cancer treatment requires achieving effective drug concentrations at the tumor site while sparing normal tissues.

    Purpose of the Study:

    • To explore advancements in drug measurement, cell kinetics, and pharmacokinetic modeling for improved cancer chemotherapy.
    • To compare the cellular and tissue penetration of amethopterin (Methotrexate) with metroprine (DDMP), focusing on brain and resistant cell entry.
    • To introduce the concept of compartmental chemotherapy for brain tumors, emphasizing selective drug delivery and tissue protection.

    Main Methods:

    • Utilized advanced methodologies for quantifying drug levels in biological samples.
    • Applied principles of cell cycle kinetics to understand drug action.
    • Developed kinetic models and computer simulations for drug distribution analysis.
    • Compared the pharmacokinetic properties and tissue penetration of amethopterin and metroprine.

    Main Results:

    • New methodologies and kinetic models enhance the selection of drug dosage, administration routes, and treatment schedules.
    • Metroprine (DDMP) demonstrates superior lipid solubility compared to amethopterin (Methotrexate), facilitating entry into the brain, cerebrospinal fluid (CSF), and amethopterin-resistant cells.
    • Pharmacokinetic differences highlight challenges in treating brain tumors with current drugs.

    Conclusions:

    • Compartmental chemotherapy, based on selective drug targeting and tissue protection, offers a promising strategy for brain tumor treatment.
    • Understanding drug pharmacokinetics and compartmental distribution is crucial for developing more effective and safer cancer therapies.
    • Further research into drug penetration and selective delivery is essential for overcoming limitations in current cancer treatment regimens.

    More Related Videos

    Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles09:56

    Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

    Published on: August 2, 2016

    A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

    A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

    Published on: September 13, 2022

    Related Concept Videos

    Principles of Drug Action01:24

    Principles of Drug Action

    Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
    Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
    Dose-Response Relationship: Selectivity and Specificity01:25

    Dose-Response Relationship: Selectivity and Specificity

    Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
    Pharmacodynamics: Overview and Principles01:21

    Pharmacodynamics: Overview and Principles

    Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
    Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
    Nonlinear Pharmacokinetics: Role of Transporters01:27

    Nonlinear Pharmacokinetics: Role of Transporters

    A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
    Polymorphisms occurring in drug transporters can alter...
    Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

    Pharmacokinetic–Pharmacodynamic Relationship: Problems

    The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
    Pharmacokinetic–Pharmacodynamic Relationship: Model Components01:14

    Pharmacokinetic–Pharmacodynamic Relationship: Model Components

    Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...